Introduction
This clinical study protocol outlines the investigation of the Philips HeartStart Intrepid 12-lead ECG device.
Study Objectives
The study aims to evaluate the safety and efficacy of the device in a clinical setting.
Study Design
The study will involve a clinical trial with a sample size of [not specified] participants, with a duration of [not specified] months.
Study Product
The study product is the Philips HeartStart Intrepid 12-lead ECG device, which will be used to collect ECG data from participants.
Study Procedures
The study will involve recruitment, screening, and enrollment of participants, followed by study visits and data collection.
Adverse Events and Unanticipated Problems
The study will monitor and report adverse events and unanticipated problems related to the device.
Manual:
Download: Philips HeartStart Intrepid 12-lead ECG Study The ICE study Protocol
Chat: Powered By VoiceSphere